Drug screening tablets affected by temperature exposure during storage
McKesson is recalling Alere Toxicology drug screening tablets due to temperature excursions during facility storage that may have reduced product effectiveness. Affected units were received between June and September 2021.
The agency’s classification
FDA (Devices): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 3/5 (High).
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This is an FDA Class II recall for a medical device with a theoretical hazard—temperature exposure potentially affecting product effectiveness. No illnesses or injuries have been reported, which per the rubric limits this to a maximum score of 3.
Plain-English summary
McKesson Medical-Surgical Inc. is recalling Alere Toxicology drug screening tablets (Model Number 7875), medical devices used for drug screening. The product was distributed nationwide in the United States.
The recall was initiated because the manufacturing facility experienced temperature excursions between June and August 2021, prior to product shipment. These temperature excursions may have compromised the product's effectiveness.
The recall applies to all lots received between June 1, 2021 and September 30, 2021.
The recalled product
- Product
- Alere Toxicology TABLET, INSTANT BLUING F/DRUGSCREEN Model Number: 7875
- Manufacturer
- Mckesson Medical-Surgical Inc. Corporate Office
- Hazard
- Affected units
- 1
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- GTIN: Unknown All lots received between 7/4/21-9/30/21
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 55 recalled by Mckesson Medical-Surgical Inc. Corporate Office under a single FDA (Devices) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 55 products in this recall →Related recalls
Same manufacturer · Mckesson Medical-Surgical Inc. Corporate Office
See all →- ModerateStrep A test kits recalled after shipment to unlicensed purchasing customers
FDA (Devices) · 2025-08-27
- ModerateProlia prefilled syringes recalled after potential temperature excursions during transit delays
FDA (Drugs) · 2025-07-30
- ModerateEvenity prefilled syringes recalled after potential temperature excursions during transit delays
FDA (Drugs) · 2025-07-30
- ModerateBenlysta vials recalled after potential temperature excursions during transit delays
FDA (Drugs) · 2025-07-30
- ModerateAbbott Diagnostics ARC Carbon Dioxide Calibrator Cold Chain Storage Issue
FDA (Devices) · 2025-06-04
Same hazard · functional failure
See all →- ModerateOlympus DisplayPort Cable Recalled for Video Dropout Risk
FDA (Devices) · 2026-10-07
- HighAccuVu Angiographic Catheter, Omni Flush, Non-Braided Defect Recall
FDA (Devices) · 2026-04-29
- HighBaxter TruSystem 7500 Hybrid software issue disables upper back adjustment
FDA (Devices) · 2025-04-02
- HighSoftware Malfunction Disables Back Control on Baxter TruSystem 7500
FDA (Devices) · 2025-04-02
- SevereCardiac catheters recalled due to polyurethane layer delamination defects
FDA (Devices) · 2024-05-22
Similar recalls
- HighIbuprofen tablets recalled nationwide due to temperature abuse during manufacturing
FDA (Drugs) · 2022-06-15
- HighMeclizine Hydrochloride Tablets Recalled for Manufacturing Temperature Control Deviations
FDA (Drugs) · 2022-06-15
- HighFDA Recalls Metoprolol Tablets Due to Temperature Abuse During Manufacturing
FDA (Drugs) · 2022-06-15
- HighFDA Recalls Olanzapine Tablets Due to Temperature Abuse in Manufacturing
FDA (Drugs) · 2022-06-15
- HighLevofloxacin 500 mg Tablets Recalled Due to Manufacturing Temperature Abuse
FDA (Drugs) · 2022-06-15
- HighMethyLPREDNISolone Acetate Injectable Suspension Recall Due to Temperature Abuse
FDA (Drugs) · 2022-06-15